TRVN

Trevena Inc

TRVN.US trevena.com + Research + Basket
CIK 0001429560
Employees 23
Phone 610 354 8840
Fiscal year end December
IPO Jan 31, 2014
Address 955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087
0.01
+0.00 (+0.00%)
USD · PINK
52-week range
0.00
0.07
Trading at 16% of the 52-week range
Market Cap
9.59K
P/E Ratio
0.00
Forward P/E
0.00
Book Value
-27.27
Div. Yield
N/A
% Institutions
11.00%
% Insiders
0.00%

1 Year

-7.5%

3 Year

-99.9%

10 Year

-100.0%
Description

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.

Actions

Add an action for TRVN.US, or sign in to see your action list.

People

▼

Directors & Officers

Name Title Year Born
Ms. Carrie L. Bourdow President, CEO & Chairman 1963
Dr. Mark A. Demitrack M.D. Senior VP & Chief Medical Officer 1958
Dr. Howard A. Rockman M.D. Scientific Founder, Consultant and Member of Scientific Advisory Board NA
Ms. Katrine Sutton Principal Financial Officer & principal accounting officer 1977
Mr. Robert T. Yoder Senior VP, Chief Business Officer, Head of Commercial Operations & Chief Compliance Officer 1966
Mr. Michael Catalano Vice President of Marketing NA

Insider Trading

Open insider trading
Date Insider Name Title Transaction Type Shares Price Value SEC
Jun 28, 2022 Barry Shin N/A Sale 50.00 $256.25 $12.81K SEC

Shareholders

▼

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
Advisor Group Holdings, Inc. 0.00 Mar 31, 2025 0.00% $0.00 -100.00%
Activest Wealth Management 0.00 Mar 31, 2025 0.00% $0.00 -100.00%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 Fidelity OTC 706.00 0.08% ▲ 0.00% Jul 31, 2026
2 Fidelity OTC Commingled Pool Class D 113.00 0.01% ▲ 0.00% Jul 31, 2026
3 Fidelity OTC K6 52.00 0.01% ▲ 0.00% Jul 31, 2026

Financial Highlights

▼
Market Cap: $9.59K
EBITDA: $-31.75M
PEG Ratio: $0.00
Book Value: $-27.27
Earnings/Share: $-290.10
Profit Margin: 0.00%
Operating Margin: -1,970.67%
ROA (TTM): -62.39%
ROE (TTM): -1,014.58%
Revenue (TTM): $546.00K
Revenue/Share (TTM): $0.69
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 57.20%

Valuation Metrics

Enterprise Value: $24.11M
Trailing P/E: 0.00
Forward P/E: 0.00

Shares Statistics

Shares Outstanding: 863.79K
Shares Float: 859.07K
% Insiders: 0.00%
% Institutions: 11.00%
Short % Float: 8.33%

Stock Price History

▼

1 Year Price History

3 Years Price History

10 Years Price History

Max Price History

Financial Charts

▼
Open balance sheet Open capital intensity Download Financials (Excel)

Revenue, Net Income & Operating Cash Flow (Yearly)

Change % vs Prior Year

Revenue, Net Income & Operating Cash Flow (Quarterly)

Change % vs Prior Quarter

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

▼
Open full waterfall Open balance sheet
Line Item
Step Type
Value
Revenue
adjust
$3.13M
Cost of Goods Sold
adjust
$-1.67M
Gross Profit
subtotal
$1.46M
SG&A
adjust
$-21.52M
R&D
adjust
$-16.33M
Operating Income
subtotal
$-35.29M
Other / Non-Operating Items
adjust
$-5.00M
Net Income
subtotal
$-40.29M

Earnings Per Share (EPS) History

▼

Financial Ratios

▼

📦 Raw API Data (JSON Explorer)

▼

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about TRVN.US!